Clinical Trials

2 enrolled

Leukemia, Biphenotypic, Acute, Neoplasm, Residual

NCT02988466 2025-05-28

Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

LymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

78 enrolled 16 charts

Bone Marrow Failure Disorders, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Follicular, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, T-Cell, Neoplasm, Residual, Lymphoma, B-Cell, Marginal Zone, Hematologic Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

NCT03524235 2024-11-12

Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

LymphoidOther hematologic neoplasmPlasma cell

20 enrolled

Hodgkin Disease, Lymphoma, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual

NCT05117879 2024-10-17

R0 Resection Rate Between CSP, cEMR and hEMR for 1-2 cm Colorectal SSLs

120 enrolled

Tumor-Agnostic

Neoplasm, Residual

NCT02169609 2024-04-22

Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

24 enrolled

CNS

Neuroblastoma, Neoplasm, Residual

NCT03096782 2023-10-11

Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

6 enrolled 10 charts

Anemia, Refractory, with Excess of Blasts, Histiocytosis, Langerhans-Cell, Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05093192 2023-09-08

Mobilising Tumour and Immune Cells Via Exercise in Chronic Lymphocytic Leukaemia

26 enrolled

Motor Activity, Leukemia, Lymphocytic, Chronic, B-Cell, Neoplasm, Residual

NCT03512197 2023-08-21

A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)

Phase 3 Completed

511 enrolled 26 charts

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT04712942 2023-08-21

Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat

14 enrolled

Myeloid

Myelodysplastic Syndromes, Neoplasm, Residual

NCT02185781 2023-03-30

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

6 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199030 2023-03-20

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

8 enrolled

Lymphoma, Recurrence, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT00198991 2022-08-18

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

1,883 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02529813 2022-06-30

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

26 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03093207 2020-11-17

Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis

34 enrolled 8 charts

Aggressive Periodontitis, Neoplasm, Residual

NCT01460498 2020-03-05

Azacitidine (AZA) in Minimal Residual Disease (MRD) Chronic Myeloid Leukemia (CML)

MyeloidOther hematologic neoplasm

3 enrolled

Leukemia, Philadelphia Chromosome, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT02870777 2020-03-04

MRD-directed Therapy for Low-risk and Intermediate-risk AML.

743 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT02673008 2020-02-25

MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCT

206 enrolled

Recurrence, Neoplasm, Residual

NCT01207388 2020-02-10

BLAST

116 enrolled 23 charts 1 FDA

Burkitt Lymphoma, Leukemia, Lymphatic Diseases, Lymphoproliferative Disorders, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01594892 2019-09-04

DOSIS

60 enrolled

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplastic Processes, Pain, Neoplasm, Residual

NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

60 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

NCT01401959 2018-06-15

Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy

127 enrolled 11 charts

Breast

Breast Neoplasms, Neoplasm, Residual

NCT01347996 2017-11-29

Maintenance Therapy With Ceplene® (Histamine) and IL-2 on Immune Response and MRD in Acute Myeloid Leukemia

84 enrolled

Leukemia, Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT02339805 2017-07-07

LymphoSeq

30 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Neoplasm, Residual

NCT00816049 2017-04-21

ALL2008con

Phase 3 Completed

775 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02900950 2016-09-15

MPM

68 enrolled

Gastrointestinal

Margins of Excision, Neoplasms, Pancreatic Neoplasms, Neoplasm, Residual

NCT00526175 2016-01-20

LAL-BR/2001: Study Treatment to Low Risk ALL

150 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00560794 2015-01-26

Phase II Study of the BiTE® Blinatumomab (MT103) in Patients With Minimal Residual Disease of B-precursor Acute Lymphoblastic Leukemia (ALL)

21 enrolled 19 charts

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00795756 2014-10-22

Intrathecal DepoCyte and Lineage-targeted Minimal Residual Disease-oriented Therapy of Acute Lymphoblastic Leukemia

145 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00267085 2012-08-07

Synthetic Vaccine in Patients With Chronic Myeloid Leukemia and Minimal Residual Disease

MyeloidOther hematologic neoplasm

11 enrolled 6 charts

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Neoplasm, Residual

NCT00358072 2010-12-29

Treatment of Adult ALL With an MRD-directed Programme.

280 enrolled

Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00199004 2010-08-23

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

60 enrolled